We are an international biopharmaceutical group, research-oriented, with over 85 years of experience. Our headquarters is located in Parma, but we export in more than 100 countries, with a direct presence in 31.
The Chiesi Group researches, develops and innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. In 2018, we changed our by-laws to become a Benefit Company, measuring our impact on society and the environment, combining the need to generate value for the business to acting as a positive force for the community in which we live. In 2019 we obtained the B Corp certification, confirmed in 2022 after a deep assessment of our internal processes.